Literature DB >> 31343240

Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.

Jacob D Jones1, Natalie E Kurniadi1, Taylor P Kuhn2, Sarah M Szymkowicz3, Joseph Bunch1, Elizabeth Rahmani1.   

Abstract

INTRODUCTION: Nonmotor symptoms, including depression, anxiety, apathy, and cognitive dysfunction, are common in Parkinson's disease (PD). Although a link between mood symptoms and cognitive impairment in PD has been theorized vis-à-vis striatal dopamine depletion, studies have been inconsistent regarding the relationship between mood symptoms and cognitive function. Inconsistencies may reflect the cross-sectional nature of previous studies. The current study examined the bidirectional longitudinal relationship between mood and cognition.
METHOD: Data were obtained from 310 individuals newly diagnosed with PD, who were followed up to 4 years (baseline, 1st, 2nd, 3rd, and 4th annual follow-ups). Apathy, anxiety, depressive symptoms, motor severity, and neurocognitive functioning were assessed at each annual assessment. The longitudinal relationship between apathy, anxiety, depressive symptoms, and cognition was analyzed with multilevel models.
RESULTS: Over the 4-year period, more severe depressive symptoms were related to worse performance on tasks of processing speed, verbal learning, and verbal delayed recall. Additionally, there was a significant Depression × Time interaction, suggesting that individuals with more severe depressive symptoms experience more rapid declines in global cognitive functioning and verbal learning. Apathy and anxiety were not significantly related to performance in any cognitive test. Lagged models revealed that changes in depression precede declines in working memory, verbal learning, delayed verbal recall, and global cognition.
CONCLUSION: Findings suggest depressive symptoms may be a harbinger for future cognitive decline among individuals with PD. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Year:  2019        PMID: 31343240      PMCID: PMC6823115          DOI: 10.1037/neu0000583

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  51 in total

Review 1.  Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry.

Authors:  Adrian M Owen
Journal:  Neuroscientist       Date:  2004-12       Impact factor: 7.519

Review 2.  Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits.

Authors:  Richard Levy; Bruno Dubois
Journal:  Cereb Cortex       Date:  2005-10-05       Impact factor: 5.357

3.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

Authors:  S J Kish; K Shannak; O Hornykiewicz
Journal:  N Engl J Med       Date:  1988-04-07       Impact factor: 91.245

Review 4.  Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment.

Authors:  Javier Pagonabarraga; Jaime Kulisevsky; Antonio P Strafella; Paul Krack
Journal:  Lancet Neurol       Date:  2015-04-12       Impact factor: 44.182

5.  Reliability, validity, and clinical correlates of apathy in Parkinson's disease.

Authors:  S E Starkstein; H S Mayberg; T J Preziosi; P Andrezejewski; R Leiguarda; R G Robinson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

6.  Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease.

Authors:  Daniel Weintraub; Katherine A Oehlberg; Ira R Katz; Matthew B Stern
Journal:  Am J Geriatr Psychiatry       Date:  2006-02       Impact factor: 4.105

7.  Cognitive Profiles in Parkinson's Disease and their Correlation with Dementia, Anxiety and Depression: A Preliminary Study.

Authors:  Wan Nor Azlen Wan Mohamed; Normah Che Din; Norlinah Ibrahim
Journal:  Malays J Med Sci       Date:  2015-12

8.  Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson's disease.

Authors:  Sara Varanese; Bernardo Perfetti; Maria Felice Ghilardi; Alessandro Di Rocco
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

9.  Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

Authors:  Nadeeka N W Dissanayaka; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; David P Breen; Tien K Khoo; Roger A Barker; David J Burn
Journal:  Parkinsonism Relat Disord       Date:  2017-01-04       Impact factor: 4.891

10.  Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort.

Authors:  Paolo Eusebi; Michele Romoli; Federico Paolini Paoletti; Nicola Tambasco; Paolo Calabresi; Lucilla Parnetti
Journal:  NPJ Parkinsons Dis       Date:  2018-11-16
View more
  8 in total

1.  Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease.

Authors:  Kyum-Yil Kwon; Suyeon Park; Rae On Kim; Eun Ji Lee; Mina Lee
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

2.  Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson's Disease.

Authors:  Jiangnan Ma; Kaixin Dou; Ruize Liu; Yajin Liao; Zengqiang Yuan; Anmu Xie
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

Review 3.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

4.  Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation Analyses.

Authors:  Sarah M Szymkowicz; Jacob D Jones; Holly Timblin; Cameron A Ryczek; Warren D Taylor; Pamela E May
Journal:  Am J Geriatr Psychiatry       Date:  2021-11-21       Impact factor: 7.996

5.  A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson's disease.

Authors:  Jacob D Jones; Brandon Dominguez; Joseph Bunch; Carmen Uribe; Yenny Valenzuela; Jonathan P Jacobs
Journal:  Clin Park Relat Disord       Date:  2021-08-10

6.  Anxiety, Depression, and Apathy as Predictors of Cognitive Decline in Patients With Parkinson's Disease-A Three-Year Follow-Up Study.

Authors:  Ketevan Toloraia; Antonia Meyer; Selina Beltrani; Peter Fuhr; Roselind Lieb; Ute Gschwandtner
Journal:  Front Neurol       Date:  2022-02-08       Impact factor: 4.003

7.  Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.

Authors:  Jacob D Jones; Carmen Uribe; Joseph Bunch; Kelsey R Thomas
Journal:  J Neurol       Date:  2020-08-17       Impact factor: 4.849

8.  Validation of Revised Chinese Version of PD-CRS in Parkinson's Disease Patients.

Authors:  Yuyan Tan; Weiguo Liu; Juanjuan Du; Miaomiao Hou; Cuiyu Yu; Yang Liu; Shishuang Cui; Lei Yan; Yizhou Lu; Hong Lv; Lijun Han; Xi Wang; Shengyu Zha; Xiaoguang Luo; Huidong Tang; Shengdi Chen
Journal:  Parkinsons Dis       Date:  2020-02-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.